Zoetis Property, Plant, and Equipment 2011-2025 | ZTS

Zoetis property, plant, and equipment from 2011 to 2025. Property, plant, and equipment can be defined as the sum of all net property, plant & Equipment fields. Where companies do not report a break down of plant, property, & equipment, the value is entered in this field alone.
  • Zoetis property, plant, and equipment for the quarter ending March 31, 2025 was $3.441B, a 5.84% increase year-over-year.
  • Zoetis property, plant, and equipment for 2024 was $3.391B, a 5.84% increase from 2023.
  • Zoetis property, plant, and equipment for 2023 was $3.204B, a 16.38% increase from 2022.
  • Zoetis property, plant, and equipment for 2022 was $2.753B, a 13.67% increase from 2021.
Zoetis Annual Property, Plant, and Equipment
(Millions of US $)
2024 $3,391
2023 $3,204
2022 $2,753
2021 $2,422
2020 $2,202
2019 $1,940
2018 $1,658
2017 $1,435
2016 $1,381
2015 $1,307
2014 $1,318
2013 $1,295
2012 $1,241
2011 $1,243
2010 $0
Zoetis Quarterly Property, Plant, and Equipment
(Millions of US $)
2025-03-31 $3,441
2024-12-31 $3,391
2024-09-30 $3,298
2024-06-30 $3,200
2024-03-31 $3,251
2023-12-31 $3,204
2023-09-30 $3,092
2023-06-30 $3,011
2023-03-31 $2,913
2022-12-31 $2,753
2022-09-30 $2,623
2022-06-30 $2,559
2022-03-31 $2,487
2021-12-31 $2,422
2021-09-30 $2,338
2021-06-30 $2,286
2021-03-31 $2,227
2020-12-31 $2,202
2020-09-30 $2,099
2020-06-30 $2,011
2020-03-31 $1,977
2019-12-31 $1,940
2019-09-30 $1,813
2019-06-30 $1,739
2019-03-31 $1,683
2018-12-31 $1,658
2018-09-30 $1,556
2018-06-30 $1,470
2018-03-31 $1,453
2017-12-31 $1,435
2017-09-30 $1,388
2017-06-30 $1,355
2017-03-31 $1,368
2016-12-31 $1,381
2016-09-30 $1,382
2016-06-30 $1,341
2016-03-31 $1,317
2015-12-31 $1,307
2015-09-30 $1,293
2015-06-30 $1,295
2015-03-31 $1,301
2014-12-31 $1,318
2014-09-30 $1,313
2014-06-30 $1,309
2014-03-31 $1,292
2013-12-31 $1,295
2013-09-30 $1,252
2013-06-30 $1,252
2013-03-31 $1,237
2012-12-31 $1,241
2012-09-30
2012-06-30
2012-03-31
2011-12-31 $2,149
2010-12-31
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $69.034B $9.256B
Zoetis Inc. is a leader in the animal health space with a focus on both livestock and companion animals in seven major product categories: vaccines, anti-infectives, parasiticides, dermatology, other pharmaceutical products, medicated feed additives and animal health diagnostics. Zoetis has a diversified business, which caters to eight core species ' cattle, swine, poultry, fish and sheep (collectively, livestock) and dogs, cats and horses (collectively, companion animals). It directly markets its products to veterinarians and livestock producers. The outstanding growth rate in the companion animal medicines, vaccines and diagnostics sector is being driven by economic development, related increases in disposable income and a rise in pet ownership and spending on pet care.Zoetis has been working on strengthening its product portfolio through acquisitions and deals.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $82.342B 30.89
Takeda Pharmaceutical (TAK) Japan $47.411B 9.43
Daiichi Sankyo, - (DSNKY) Japan $44.972B 23.05
BeOne Medicines - (ONC) Cayman Islands $27.694B 0.00
Sandoz Group AG (SDZNY) Switzerland $23.360B 0.00
Merck (MKKGY) Germany $16.226B 11.89
Summit Therapeutics (SMMT) United States $14.972B 0.00
Shionogi (SGIOY) Japan $14.581B 14.61
United Therapeutics (UTHR) United States $13.159B 11.64
Neurocrine Biosciences (NBIX) United States $12.599B 43.16
Orion OYJ (ORINY) Finland $10.006B 27.06
IPSEN (IPSEY) France $9.836B 0.00
Corcept Therapeutics (CORT) United States $7.555B 61.41
Stevanato Group S.p.A (STVN) Italy $7.193B 43.98
Madrigal Pharmaceuticals (MDGL) United States $6.277B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Grifols, S.A (GRFS) Spain $5.982B 0.00
Ionis Pharmaceuticals (IONS) United States $5.890B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.031B 15.30
Soleno Therapeutics (SLNO) United States $4.000B 0.00
Hypermarcas (HYPMY) Brazil $3.132B 20.60
Crinetics Pharmaceuticals (CRNX) United States $2.856B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.782B 9.75
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.489B 13.46
BioCryst Pharmaceuticals (BCRX) United States $2.084B 0.00
Recursion Pharmaceuticals (RXRX) United States $2.077B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.043B 0.00
Indivior (INDV) United States $1.917B 8.13
Centessa Pharmaceuticals (CNTA) United Kingdom $1.693B 0.00
Endo (NDOI) United States $1.618B 0.00
ARS Pharmaceuticals (SPRY) United States $1.563B 0.00
Evotec AG (EVO) Germany $1.410B 0.00
Ocular Therapeutix (OCUL) United States $1.327B 0.00
Guardian Pharmacy Services (GRDN) United States $1.245B 0.00
Dyne Therapeutics (DYN) United States $1.225B 0.00
Harrow (HROW) United States $1.156B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.070B 21.41
Enliven Therapeutics (ELVN) United States $1.058B 0.00
Verve Therapeutics (VERV) United States $0.991B 0.00
Collegium Pharmaceutical (COLL) United States $0.951B 5.13
Akebia Therapeutics (AKBA) United States $0.935B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.902B 0.00
Ardelyx (ARDX) United States $0.864B 0.00
Cronos Group (CRON) Canada $0.737B 0.00
Xeris Biopharma Holdings (XERS) United States $0.716B 0.00
Elite Pharmaceuticals (ELTP) United States $0.716B 0.00
KalVista Pharmaceuticals (KALV) United States $0.612B 0.00
Xencor (XNCR) United States $0.595B 0.00
Relay Therapeutics (RLAY) United States $0.576B 0.00
Regulus Therapeutics (RGLS) United States $0.568B 0.00
USANA Health Sciences (USNA) United States $0.567B 12.32
Altimmune (ALT) United States $0.550B 0.00
Theravance Biopharma (TBPH) United States $0.531B 0.00
Bioventus (BVS) United States $0.528B 13.40
AleAnna (ANNA) United States $0.520B 0.00
Zevra Therapeutics (ZVRA) United States $0.496B 0.00
Siga Technologies (SIGA) United States $0.459B 9.58
Amylyx Pharmaceuticals (AMLX) United States $0.455B 0.00
Oruka Therapeutics (ORKA) United States $0.449B 0.00
Tourmaline Bio (TRML) United States $0.432B 0.00
Organogenesis (ORGO) United States $0.415B 0.00
Savara (SVRA) United States $0.358B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.346B 9.35
Aquestive Therapeutics (AQST) United States $0.338B 0.00
Liminatus Pharma (LIMN) United States $0.333B 0.00
Heron Therapeutics (HRTX) United States $0.305B 0.00
Nature's Sunshine Products (NATR) United States $0.270B 24.83
Tonix Pharmaceuticals Holding (TNXP) United States $0.253B 0.00
Esperion Therapeutics (ESPR) United States $0.218B 0.00
MediWound (MDWD) Israel $0.210B 0.00
Galectin Therapeutics (GALT) United States $0.208B 0.00
ProKidney (PROK) United States $0.204B 0.00
Profound Medical (PROF) Canada $0.203B 0.00
Nanobiotix S.A (NBTX) France $0.202B 0.00
OmniAb (OABI) United States $0.202B 0.00
Aldeyra Therapeutics (ALDX) United States $0.190B 0.00
4D Molecular Therapeutics (FDMT) United States $0.189B 0.00
Larimar Therapeutics (LRMR) United States $0.175B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.155B 0.00
Aclaris Therapeutics (ACRS) United States $0.154B 0.00
Journey Medical (DERM) United States $0.148B 0.00
Innate Pharma SA (IPHYF) France $0.145B 0.00
Lyell Immunopharma (LYEL) United States $0.142B 0.00
Lexeo Therapeutics (LXEO) United States $0.141B 0.00
VAXART, INC (VXRT) United States $0.140B 0.00
Avita Medical (RCEL) United States $0.139B 0.00
Inhibikase Therapeutics (IKT) United States $0.126B 0.00
Korro Bio (KRRO) United States $0.117B 0.00
Champions Oncology (CSBR) United States $0.116B 19.09
Protara Therapeutics (TARA) United States $0.115B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.113B 0.00
Cardiol Therapeutics (CRDL) Canada $0.109B 0.00
Achieve Life Sciences (ACHV) Canada $0.109B 0.00
Nektar Therapeutics (NKTR) United States $0.107B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.102B 0.00
Cassava Sciences (SAVA) United States $0.100B 0.00
Fractyl Health (GUTS) United States $0.094B 0.00
Dominari Holdings (DOMH) United States $0.092B 0.00
Wellgistics Health (WGRX) United States $0.088B 0.00
Nutriband (NTRB) United States $0.087B 0.00
Surrozen (SRZN) United States $0.085B 0.00
Unicycive Therapeutics (UNCY) United States $0.084B 0.00
Arch Biopartners (ACHFF) Canada $0.084B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.080B 59.56
ESSA Pharma (EPIX) Canada $0.075B 0.00
Inotiv (NOTV) United States $0.075B 0.00
Pyxis Oncology (PYXS) United States $0.071B 0.00
Vivani Medical (VANI) United States $0.068B 0.00
Assertio Holdings (ASRT) United States $0.063B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
PMV Pharmaceuticals (PMVP) United States $0.057B 0.00
NRx Pharmaceuticals (NRXP) United States $0.056B 0.00
Metagenomi (MGX) United States $0.055B 0.00
Rafael Holdings (RFL) United States $0.055B 0.00
Gain Therapeutics (GANX) United States $0.054B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.054B 0.00
Telomir Pharmaceuticals (TELO) United States $0.052B 0.00
Avalo Therapeutics (AVTX) United States $0.052B 0.00
Context Therapeutics (CNTX) United States $0.051B 0.00
Century Therapeutics (IPSC) United States $0.051B 0.00
Klotho Neurosciences (KLTO) United States $0.049B 0.00
Prelude Therapeutics (PRLD) United States $0.049B 0.00
Mural Oncology (MURA) Ireland $0.043B 0.00
Jupiter Neurosciences (JUNS) United States $0.041B 0.00
Iterum Therapeutics (ITRM) Ireland $0.040B 0.00
ElectroCore (ECOR) United States $0.039B 0.00
Acrivon Therapeutics (ACRV) United States $0.039B 0.00
Karyopharm Therapeutics (KPTI) United States $0.038B 0.00
PolyPid (PYPD) Israel $0.034B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.032B 0.00
China SXT Pharmaceuticals (SXTC) China $0.030B 0.00
SCYNEXIS (SCYX) United States $0.029B 0.00
Tempest Therapeutics (TPST) United States $0.025B 0.00
Enlivex Therapeutics (ENLV) Israel $0.025B 0.00
Relmada Therapeutics (RLMD) United States $0.023B 0.00
Natural Alternatives (NAII) United States $0.021B 0.00
Carisma Therapeutics (CARM) United States $0.021B 0.00
FibroGen (FGEN) United States $0.021B 0.00
DURECT (DRRX) United States $0.020B 0.00
BioVie (BIVI) United States $0.020B 0.00
BioLineRx (BLRX) Israel $0.019B 0.00
Ernexa Therapeutics (ERNA) United States $0.019B 0.00
Lipocine (LPCN) United States $0.017B 0.00
CASI Pharmaceuticals (CASI) China $0.017B 0.00
Mannatech (MTEX) United States $0.017B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.017B 0.00
ProPhase Labs (PRPH) United States $0.015B 0.00
Vivos Therapeutics (VVOS) United States $0.015B 0.00
VYNE Therapeutics (VYNE) United States $0.014B 0.00
Lyra Therapeutics (LYRA) United States $0.014B 0.00
Scienture Holdings (SCNX) United States $0.013B 0.00
Minerva Neurosciences (NERV) United States $0.013B 2.21
TherapeuticsMD (TXMD) United States $0.013B 0.00
Cosmos Health (COSM) United States $0.012B 0.00
Phio Pharmaceuticals (PHIO) United States $0.011B 0.00
Ainos (AIMD) United States $0.011B 0.00
Mangoceuticals (MGRX) United States $0.010B 0.00
Talphera (TLPH) United States $0.010B 0.00
Citius Pharmaceuticals (CTXR) United States $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
Traws Pharma (TRAW) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
SHINECO (SISI) China $0.007B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.007B 0.00
Incannex Healthcare (IXHL) Australia $0.007B 0.00
Alaunos Therapeutics (TCRT) United States $0.007B 0.00
TransCode Therapeutics (RNAZ) United States $0.006B 0.00
Aptorum Group (APM) United Kingdom $0.006B 0.00
Indaptus Therapeutics (INDP) United States $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
CERo Therapeutics Holdings (CERO) United States $0.004B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
Plus Therapeutics (PSTV) United States $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
Jaguar Animal Health (JAGX) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00